BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ahmadi Bidakhvidi N, Goffin K, Dekervel J, Baete K, Nackaerts K, Clement P, Van Cutsem E, Verslype C, Deroose CM. Peptide Receptor Radionuclide Therapy Targeting the Somatostatin Receptor: Basic Principles, Clinical Applications and Optimization Strategies. Cancers (Basel) 2021;14:129. [PMID: 35008293 DOI: 10.3390/cancers14010129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Imperiale A. Neuroendocrine Tumors: Treatment and Management. Cancers (Basel) 2022;14:4048. [PMID: 36011040 DOI: 10.3390/cancers14164048] [Reference Citation Analysis]
2 Gubbi S, Koch CA, Klubo-Gwiezdzinska J. Peptide Receptor Radionuclide Therapy in Thyroid Cancer. Front Endocrinol (Lausanne) 2022;13:896287. [PMID: 35712243 DOI: 10.3389/fendo.2022.896287] [Reference Citation Analysis]